• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Thinking about hitching a ride on a mission to Mars? One hazard you haven’t considered

Bioengineer by Bioengineer
April 17, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: NASA

WASHINGTON, D.C. – April 17, 2018 — The hazards of space flight are well known: freezing temperatures, the vacuum of space, radiation, isolation. But there's a lesser-known risk getting the attention of researchers – a possible danger to vision. Retired NASA astronaut David Wolf, M.D., will provide insight into how space flight affects the eye on Thursday, April 19, when he gives the keynote address during a conference attended by many of the nation's leading eye physicians and surgeons, hosted by the American Academy of Ophthalmology in Washington, D.C.

One of the few people on Earth who know what it's like to leave it, Dr. Wolf logged 168 days in space over four separate space shuttle missions, including 128 days aboard the Russian Mir space station. He also led the spacewalk team that constructed the International Space Station.

Dr. Wolf will discuss his experience, including the ways space flight changes the structure of the eye. Many astronauts have experience worsening eye sight after their missions, some for years after returning to earth. The leading theory is that microgravity causes a mild but persistent pressure rise in the head. This increase in pressure stimulates the eye to reshape, causing visual impairment.

Researchers are now using the same imaging techniques that ophthalmologists use every day to find solutions to the damaging effects of space travel on vision. This research is critical as the U.S. prepares for longer spaceflights to the International Space Station, moon, asteroid belt or Mars.

In February, Vice President Mike Pence appointed Wolf to serve on the new Users Advisory Group for the National Space Council. The group is sponsored by NASA and reports to the National Space Council on a range of issues. It will give direction on U.S. space policy.

Dr. Wolf served as a U.S. Air Force senior flight surgeon in the Air National Guard (1983 to 2004), achieving the rank of Lt. Colonel. An electrical engineer and inventor, he pioneered the development of modern medical ultrasonic image processing techniques, and has been awarded 17 U.S. patents. He also received the NASA Exceptional Engineering Achievement Medal in 1990, and was named NASA Inventor of the Year in 1992.

In 2011, Wolf was inducted into the Space Foundation's Space Technology Hall of Fame for his work in developing the bioreactor, a device that enables the growth of tissue, cancer tumors and virus cultures outside the body in space and on earth.

###

About the American Academy of Ophthalmology

The American Academy of Ophthalmology is the world's largest association of eye physicians and surgeons. A global community of 32,000 medical doctors, we protect sight and empower lives by setting the standards for ophthalmic education and advocating for our patients and the public. We innovate to advance our profession and to ensure the delivery of the highest-quality eye care. Our EyeSmart® program provides the public with the most trusted information about eye health. For more information, visit aao.org.

About Astronaut David Wolf, MD EE

As a Medical Doctor (Indiana U.), Electrical Engineer (Purdue U.), Military Officer (LTC Ret USAF ANG), and former NASA Astronaut (168 days, 4 missions, 7 Spacewalks); Dr. David Wolf now directs this multi-disciplinary background to two start-up companies in the medical field directed at resolving the constriction in the pipeline of "Pharmaceutical Molecule Discovery" and the other utilizing Regenerative Medicine techniques originally developed in NASA laboratories under his direction and which has generated several successful spinoff biotechnology companies. Dr. Wolf was engaged in patent portfolio strategy (he has 17 U.S. Patents), technology transfer to the private sector, and now further developing the next advances as a clinical medical regenerative tissue treatment. Dr. Wolf is a dual appointed Professor of Aeronautics and Aerospace Engineering and BioEngineering at Purdue University (visiting). As an Astronaut, Dr. Wolf was Chief of the Astronaut Office Extravehicular Mobility Branch overseeing "spacewalk" training through real time execution for much of the construction of The International Space Station. He is an active public speaker on risk management of critical operations in resource limited environments as well conveying the energy of our Space Program. He is an Advisor to Vice President Mike Pence for civil, national security, and commercial "Space" and sits on the National Space Council (User's Panel). For more please visit http://www.AstronautDavidWolf.com. #WeBelieveInAstronauts

Media Contact

Jennifer Churchill
[email protected]
415-561-8534
@aao_ophth

http://www.aao.org

Original Source

https://www.aao.org/newsroom/news-releases/detail/thinking-about-hitching-ride-on-mission-to-mars

Share12Tweet8Share2ShareShareShare2

Related Posts

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

February 7, 2026

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

February 7, 2026

Early Tuberculosis Treatment Lowers Sepsis Mortality in People with HIV

February 7, 2026

Structure-Guided Development of Picomolar Macrocyclic Inhibitors Targeting TRPC5 Channels with Antidepressant Effects

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

Early Tuberculosis Treatment Lowers Sepsis Mortality in People with HIV

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.